Literature DB >> 6607716

Progressive immune failure in dyskeratosis congenita. Report of an adult in whom Pneumocystis carinii and fatal disseminated candidiasis developed.

H P Wiedemann, J McGuire, J M Dwyer, J Sabetta, J B Gee, G J Smith, J Loke.   

Abstract

Community-acquired Pneumocystis carinii pneumonia developed in a young adult patient with dyskeratosis congenita. His hospitalization ended fatally with disseminated candidiasis. Evaluation during the admission showed evidence of cellular immune dysfunction as indicated by skin test anergy and absent lymphocyte proliferation in an in vitro mixed lymphocyte culture. Treatment with transfer factor failed to reverse the cutaneous anergy or affect the clinical course. Dyskeratosis congenita is a rare multisystem disorder with prominent dermatologic manifestations; bone marrow failure or malignant neoplasm are common fatal outcomes. Immune system abnormalities are not classically considered a part of the disease complex. Serial evaluation of our patient's condition over several years suggests that depressed immune function, especially of the cellular limb, may evolve as a feature of clinical importance in these patients.

Entities:  

Mesh:

Year:  1984        PMID: 6607716

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  7 in total

Review 1.  Extrahematopoietic manifestations of the short telomere syndromes.

Authors:  Kristen E Schratz
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2020-12-04

2.  Dyskeratosis congenita.

Authors:  H R Davidson; J M Connor
Journal:  J Med Genet       Date:  1988-12       Impact factor: 6.318

3.  Clastogen-induced fragility may differentiate pancytopenia of congenital dyskeratosis from Fanconi anaemia.

Authors:  A Schneider; U Mayer; E Gebhart; D Harms; J Gromball; U Glöckel; J D Beck
Journal:  Eur J Pediatr       Date:  1988-10       Impact factor: 3.183

4.  Dyskeratosis congenita (Zinsser-Cole-Engman syndrome). An autopsy case presenting with rectal carcinoma, non-cirrhotic portal hypertension, and Pneumocystis carinii pneumonia.

Authors:  K Kawaguchi; H Sakamaki; Y Onozawa; M Koike
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1990

5.  Clinical and Molecular Heterogeneity of RTEL1 Deficiency.

Authors:  Carsten Speckmann; Sushree Sangita Sahoo; Marta Rizzi; Shinsuke Hirabayashi; Axel Karow; Nina Kathrin Serwas; Marc Hoemberg; Natalja Damatova; Detlev Schindler; Jean-Baptiste Vannier; Simon J Boulton; Ulrich Pannicke; Gudrun Göhring; Kathrin Thomay; J J Verdu-Amoros; Holger Hauch; Wilhelm Woessmann; Gabriele Escherich; Eckart Laack; Liliana Rindle; Maximilian Seidl; Anne Rensing-Ehl; Ekkehart Lausch; Christine Jandrasits; Brigitte Strahm; Klaus Schwarz; Stephan R Ehl; Charlotte Niemeyer; Kaan Boztug; Marcin W Wlodarski
Journal:  Front Immunol       Date:  2017-05-01       Impact factor: 7.561

6.  Dyskeratosis congenita.

Authors:  Lorenzo Gitto; Robert Stoppacher; Timothy Eric Richardson; Serenella Serinelli
Journal:  Autops Case Rep       Date:  2020-09-02

7.  Fatal bilateral pneumothoraces complicating dyskeratosis congenita: a case report.

Authors:  Adel Boueiz; Marwan S Abougergi; Carlos Noujeim; Edmond Bou Assaf; Ghassan Jamaleddine
Journal:  J Med Case Rep       Date:  2009-03-26
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.